Go to:
Logótipo
You are in:: Start > Publications > View > Separation of racemic chiral drugs using immobilized CHIRALPAK IA: methodology for preparative scale development
Map of Premises
FC6 - Departamento de Ciência de Computadores FC5 - Edifício Central FC4 - Departamento de Biologia FC3 - Departamento de Física e Astronomia e Departamento GAOT FC2 - Departamento de Química e Bioquímica FC1 - Departamento de Matemática
Publication

Separation of racemic chiral drugs using immobilized CHIRALPAK IA: methodology for preparative scale development

Title
Separation of racemic chiral drugs using immobilized CHIRALPAK IA: methodology for preparative scale development
Type
Article in International Scientific Journal
Year
2009
Authors
Miriam Zabkova
(Author)
FEUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications Without AUTHENTICUS Without ORCID
Michal Zabka
(Author)
FEUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications Without AUTHENTICUS Without ORCID
Alírio E. Rodrigues
(Author)
FEUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Pages: 275-303
ISSN: 0149-6395
Publisher: Taylor & Francis
Indexing
Publicação em ISI Web of Science ISI Web of Science
COMPENDEX
Scientific classification
FOS: Engineering and technology > Chemical engineering
CORDIS: Technological sciences > Engineering > Chemical engineering
Other information
Authenticus ID: P-003-S4J
Abstract (EN): Immobilized stationary phases represent a new perspective for analytical as well as preparative scale separation of chiral species. In this study, the basic data necessary for further development of the production-scale processes using CHIRALPAK IA columns were acquired. The new immobilized chiral stationary phase CHIRALPAK IA has proven to be useful for the chiral separations of propranolol, metoprolol, guaifenesin, and -Tetralol enantiomers. A broad range of standard and non-standard solvents used as components of mobile phases were tested and their influence on the separations was evaluated. A satisfactory separation considering further utilization of simulated moving bed chromatography was found for propranolol, guaifenesin, and -tetralol using the following mobile phases n-Heptane/methanol/ethanolamine (05/95/0.1, v/v/v), n-Heptane/ethanol (85/15, v/v) and n-Heptane/DCM (85/15, v/v), respectively. Inverse size exclusion chromatography was implemented to measure the porosity of the column using the set of polystyrene standards. The multicomponent adsorption equilibrium was characterized by linear + Langmuir model for -Tetralol and linear model for propranolol and guaifenesin due to their limited solubility in selected mobile phases. The isotherm model was successfully validated by comparison of pulse profiles obtained by solving the mathematical model and those obtained experimentally.
Language: English
Type (Professor's evaluation): Scientific
Contact: arodrig@fe.up.pt
No. of pages: 29
Documents
We could not find any documents associated to the publication with allowed access.
Related Publications

Of the same journal

Zeolite Apgiia for Adsorption Based Carbon Dioxide Capture (2013)
Article in International Scientific Journal
Liu, Z; Shen, CZ; Filipe Lopes; Li, P; Yu, JG; Grande, CA; Alírio Rodrigues
Wet Air Oxidation of Aniline Using Carbon Foams and Fibers Enriched with Nitrogen (2010)
Article in International Scientific Journal
Juliana P.S. Sousa; Adrián M. T. Silva; Manuel F. R. Pereira; José L. Figueiredo
Vacuum Pressure Swing Adsorption to Produce Polymer-Grade Propylene (2010)
Article in International Scientific Journal
Carlos A. Grande; Frank Poplow; Alírio E. Rodrigues

See all (55)

Recommend this page Top
Copyright 1996-2024 © Faculdade de Ciências da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z  I Guest Book
Page created on: 2024-10-02 at 14:03:23 | Acceptable Use Policy | Data Protection Policy | Complaint Portal